As part of its efforts to strengthen its presence and expand its geographical expansion in the MENA region, Tabuk Pharmaceuticals inaugurated a new manufacturing site in in Blida, Algeria. Blida site covers an area of 6,200 square meters and a construction area of more than 3,000 square meters. The highest standards of quality and automation have been adopted at various stages of manufacturing to be classified as one of the advanced factories in the region. Blida site is currently manufacturing oral solid dosage forms as tablets and capsules with current and future plans to expand its scope of work to include new production lines to manufacture other pharmaceutical preparations such as liquid preparations and nasal sprays. Annual production capacity is around 150 Million (Base Unit Measurement) including oral solids, liquid bottles, and nasal preparations
